MedTrace Logo

Efficacy of Carbetocin Versus Oxytocin Plus Misoprostol in Decreasing Blood Loss During Cesarean Section

NCT05664659 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2023-07-24

No results posted yet for this study

Summary

The aim of this clinical trial is to test if carbetocin is as effective as oxytocin plus misoprostol in decreasing intraoperative blood loss in women undergoing planned cesarean section.

The main question it aims to answer is:

\* Is carbetocin as effective as oxytocin plus misoprostol in decreasing intraoperative blood loss in women undergoing planned cesarean section?

Researchers will compare 2 groups:

* women receiving Oxytocin plus Misoprostol;
* women receiving Carbetocin as regards:
* estimated blood loss

Conditions

  • Blood Loss, Surgical
  • Intrapartum Hemorrhage

Interventions

DRUG

Oxytocin + misoprostol

600 micrograms misoprostol rectally 20 IU Oxytocin IV infusion on 1000 ml of normal saline solution

DRUG

Carbetocin

100 micrograms carbetocin

Sponsors & Collaborators

  • Ain Shams Maternity Hospital

    lead OTHER

Principal Investigators

  • Mohamed SE Sweed, MD · Ain Shams University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-20
Primary Completion
2023-04-30
Completion
2023-05-20

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05664659 on ClinicalTrials.gov